Octreotide Impurity 13 is an octreotide-related peptide characterized as a specific process or degradation product. Small differences in sequence or protecting-group history change its cyclization, ring conformation, and retention behavior. Researchers use it to establish impurity thresholds and validate analytical separation. Applications include QC profiling, process-development analysis, and structural-variant comparison.
CAT No: R2764
CAS No:1546983-33-8
Synonyms/Alias:(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-N-acetyl-19-((R)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-16-benzyl-N-((2R,3R)-1,3-dihydroxybutan-2-yl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More